Restless Legs Syndrome (RLS) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034
Restless Legs Syndrome (RLS) Market Outlook Thelansis’s “Restless Legs Syndrome (RLS) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Restless Legs Syndrome (RLS) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Restless Legs Syndrome (RLS) Overview Restless legs syndrome (RLS) is a neurological condition that causes an uncomfortable or unpleasant sensation in the legs and an irresistible urge to move them. It is also known as Willis-Ekbom disease. The symptoms typically begin in the late afternoon or evening and worsen at night, often interfering with sleep. This can make falling asleep or returning to sleep after waking up c...